SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as its community grapples with mixed sentiments amidst ongoing price stagnation, despite some believing a potential merger involving Zero Hash and Mastercard, alongside progress on the Clarity Act, could be catalysts. Many holders are expressing frustration over consistent declines, while others are actively accumulating, pointing to Flexa's real-world utility with major merchants and recent patents as reasons for long-term optimism. The debate rages between those who see it as a foundational payment collateral token and those who fear it's a 'dead project' that continually disappoints.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing highly polarized sentiment, with many in the community expressing frustration over significant losses and year-end tax-loss selling contributing to downward pressure. Despite widespread discussions questioning its utility and sustained underperformance relative to other major cryptocurrencies, a dedicated segment of holders maintains long-term conviction, eagerly anticipating a future resurgence.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending with a massive volume surge and price rally following news of a strategic manufacturing partnership aimed at scaling production of its drug screening reader for future U.S. market entry. The community is intensely divided, with bulls pointing to the low float and the positive impact of a $10 million private placement on its balance sheet, while bears express significant concern over dilution, the company's reverse split history, and the offering's terms.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to massive trading volume and a significant price surge, sparking intense community discussion around its low-float SPAC nature. Traders are actively anticipating further upward movement and a potential squeeze, drawing parallels to other recently explosive micro-cap plays that have experienced rapid ascents.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is generating significant buzz as a low-float SPAC, with traders actively discussing its potential for a substantial price run. The community is drawing strong parallels to recent 'shell company rippers' like ESHA, anticipating a considerable upward movement fueled by limited circulating shares and growing speculative interest.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to its new integration with a Stripe-owned fiat anchor, which enables seamless, compliant bank-to-stablecoin transfers at a verified 11 million transactions per second. The community sees it as a potentially undervalued Layer 1 blockchain, poised to become essential financial infrastructure for institutions by offering high-speed, regulated settlement rails. This focus on enterprise-grade plumbing for global finance differentiates it from many other crypto projects.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant upward momentum as the FDA granted Priority Review for its AXS-05 in Alzheimer's disease agitation, with a PDUFA target date of April 30, and confirmed a clear path for its AXS-12 narcolepsy treatment. This major regulatory progress, alongside robust Auvelity sales growth and numerous analyst price target increases, has ignited strong bullish sentiment across the community. Many are celebrating long-term holdings and are optimistic about Axsome's potential to capitalize on substantial market opportunities in CNS disorders.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending with significant community anticipation for the start of a new yearly cycle, driving strong bullish sentiment for substantial long-term gains. Many investors are actively accumulating, citing historical patterns that suggest an imminent upward trajectory. The discussion is marked by strong convictions from bulls, despite ongoing skepticism from bears regarding its immediate outlook.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending amid intense community debate, primarily driven by widespread shareholder frustration with CEO Richard Paulson and the board, whom many accuse of continuous value destruction and mismanagement. Recent financing and a reverse stock split, while extending the cash runway, have amplified concerns about dilution and executive accountability. Despite this pervasive negative sentiment toward leadership, significant bullish options activity and anticipation for upcoming Phase 3 trial readouts in Myelofibrosis and Endometrial Cancer highlight an underlying belief in the company's scientific potential, contingent on a change in management.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent strategic moves, including pipeline expansion through acquisitions and manufacturing advancements for its lead anticoagulant candidate, Tecarfarin. The market is weighing the potential of these developments, including analyst-assigned price targets and FDA designations, against community concerns about cash burn, dilution, and the company's ability to fund pivotal Phase 3 trials. This creates a polarized discussion, highlighting the high-stakes nature of micro-cap biopharma investments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. Commerce Secretary Howard Lutnick said on Wednesday that the Trump administration has struck trade deals with Thailand and Cambodia, days after the countries agreed to a truce following deadly clashes due to a border dispute.In an interview with Fox News’s Sean Hannity, Lutnick said, “And you know what we did today? We made trade deals with Cambodia and Thailand.” However, he did not divulge any details before the interview ended.Both Thailand and Cambodia were slated to face a tariff rate of 36% from Friday, which would have dealt a blow to the trade-reliant countries as the U.S. is their largest destination for exported goods. Neighbors Indonesia and the Philippines have already secured lower rates of 19%, while Vietnam has agreed to 20% tariffs on its goods.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/THD">iShares MSCI Thailand ETF</a> (THD) was in the ‘neutral’ territory at the time of writing. At the same time, traders were ‘bullish’ about iShares MSCI Emerging Markets Asia ETF (EEMA).U.S. President Donald Trump has thus far utilized trade as a potent tool to mitigate global conflicts. He had threatened to pull out of trade discussions with both countries unless they agreed to a ceasefire after fatal clashes claimed the lives of dozens.According to a Bloomberg News <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-31/us-made-trade-deals-with-thailand-cambodia-lutnick-says">report</a>, Sun Chanthol, the Cambodian Deputy Prime Minister leading the trade talks, stated that he was unaware of any new agreement. Thailand reportedly expects the final levy to be between 18% and 20%, similar to its regional neighbors.The U.S. goods trade deficit with Thailand reached $45.6 billion in 2024, and $12.1 billion with Cambodia, which has a smaller economy than its neighbor. Thailand and Cambodia have already offered concessions to sweeten the tariff blow.Other countries are also rushing to ink a deal with the U.S. ahead of the Aug. 1 deadline. South Korea agreed to a 15% tariff rate, while the White House levied 25% tariffs on India and threatened a penalty for the country’s oil imports from Russia.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/china-factory-activity-slips-despite-trade-us-truce-is-the-dragon-losing-its-fire/chohDrgR5Cv">China Factory Activity Slips Despite Trade US Truce — Is The Dragon Losing Its Fire?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Howard Lutnick listens as U.S. President Donald Trump delivers remarks before Lutnick is sworn in as Commerce Secretary in the Oval Office at the White House on February 21, 2025.

Lutnick Says US Struck Trade Deals With Thailand, Cambodia Following Ceasefire — But Details Unclear

Both Southeast Asian countries were slated to face a tariff rate of 36% from Friday.

Equity

Several Asian economies are racing to strike last-minute trade deals with the U.S. ahead of an Aug. 1 deadline that could trigger steep new tariffs under President Donald Trump’s global tariff strategy.South KoreaSouth Korea’s top trade official said Monday that the country may reach an “agreement in principle” with the U.S. on tariffs before the Aug. 1 deadline, according to local media cited by&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/society-equity/south-korea-trade-envoy-may-be-able-strike-framework-deal-with-us-by-aug-1-2025-07-14/">Reuters</a>.&nbsp;Trade Minister Yeo Han-koo, following high-level talks in Washington last week, said “twenty days are not enough to come up with a perfect treaty that contains every detail,” and noted “considerable progress” on industrial cooperation.Yeo said that South Korea may need to make a “strategic judgment” on&nbsp;the agriculture and livestock sectors, suggesting that while “sensitive” areas may require protection, some aspects could be considered within the broader deal framework.&nbsp;He added that South Korea is working to avoid “unfair” U.S. tariffs on autos and steel that could damage industrial ties with its closest security ally.Trump said, “South Korea wants to make a deal right now,” without providing details.South Korea is hoping to avoid a 25% tariff set to begin Aug. 1, after a delayed start to negotiations following President Lee Jae-myung’s June 4 inauguration.&nbsp;According to Korea Customs Service data, South Korea recorded a $55.6 billion trade surplus with the U.S. in 2024, up 25% from the prior year due to rising car exports.ThailandIn Thailand, Finance Minister Pichai Chunhavajira said Monday the government is considering zero tariffs on more U.S. imports, according to&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/asia-pacific/thailand-considering-offering-zero-tariffs-more-us-imports-finance-minister-says-2025-07-14/">Reuters</a>.&nbsp;He also said 200 billion baht ($6.1 billion) in soft loans would be made available to cushion the blow from U.S. tariffs.&nbsp;Thailand faces a 36% tariff from Washington if no agreement is reached before Aug.1.VietnamVietnamese Prime Minister Pham Minh Chinh said Friday that the U.S. and Vietnam have reached a consensus on a tariff deal framework, according to&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-13/vietnam-urges-us-business-group-to-help-in-tariff-talks-media">Bloomberg</a>, citing local media outlet The Investor.&nbsp;Chinh made the remarks during a meeting with the U.S.-ASEAN Business Council in Hanoi, which includes companies such as Apple, Boeing, and Amazon.Vietnam was&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-11/vietnam-surprised-by-trump-tariff-announcement-seeks-lower-rate">reportedly</a> surprised by Trump’s recent announcement of a 20% tariff deal, and the country is now supposedly seeking a lower rate.&nbsp;Chinh urged U.S. businesses to support a detailed agreement on product-level terms, oppose trade defense actions against Vietnamese goods, and press the U.S. to recognize Vietnam as a market economy.JapanMeanwhile, tensions have also emerged in U.S.-Japan trade relations.&nbsp;Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/asia-pacific/rubio-says-no-drama-or-division-us-relations-with-japan-2025-07-11/">reported</a> Friday that the U.S. Secretary of State Marco Rubio downplayed concerns, saying there was “no drama or division,” despite Japanese Prime Minister Shigeru Ishiba stating Thursday that Japan needed to reduce dependence on the U.S. in areas like security, food, and energy.Trump announced a 25% tariff on Japanese imports last week.&nbsp;Japanese media previously reported the U.S. had asked Japan and other Asian allies to raise defense spending to 5% of GDP, which the Financial Times said led to Japan canceling a key bilateral defense and foreign ministers meeting.Rubio rejected claims of pressure, saying Washington merely encouraged Tokyo to invest in certain capabilities.He added that Japan's push for greater military autonomy was welcomed by the U.S. “Anyone looking for drama or division... shouldn’t be doing it,” Rubio said.&nbsp;A former Biden official told Reuters the relationship was strained, but said tensions could ease if a deal is reached by Aug. 1.On Stocktwits,&nbsp;<a href="https://stocktwits.com/symbol/EWY">iShares MSCI South Korea ETF (EWY)</a> and iShares&nbsp;<a href="https://stocktwits.com/symbol/EWJ">MSCI Japan ETF (EWJ)</a> both saw ‘high’ message volume, with sentiment rated ‘neutral’ for EWY and ‘bearish’ for EWJ.<a href="https://stocktwits.com/symbol/THD">iShares MSCI Thailand ETF (THD)</a> recorded ‘neutral’ sentiment with ‘extremely high’ message volume.&nbsp;<a href="https://stocktwits.com/symbol/VNM">VanEck Vietnam ETF (VNM)</a> showed ‘extremely bullish’ sentiment amid ‘extremely high’ message volume.Meanwhile,&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust (SPY)</a> showed ‘bearish’ sentiment amid ‘low’ message volume.See also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oil-prices-edge-higher-as-trump-teases-russia-sanctions/ch8BjnnR5Nt">Oil Prices Edge Higher As Trump Teases Russia Sanctions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sentiment on Stocktwits for iShares MSCI South Korea ETF (EWY), iShares MSCI Japan ETF (EWJ), iShares MSCI Thailand ETF (THD), VanEck Vietnam ETF (VNM), SPDR S&P 500 ETF Trust (SPY) were mixed ahead of Trump's August 1 Deadline/ Photo credit: Getty Images

Asia Braces For Trump’s Tariffs: South Korea, Thailand, Vietnam, Japan Scramble Ahead Of August Deadline

Trump’s tariff push is drawing responses across Asia, with Vietnam pushing for revisions, Japan signaling strategic shifts, and South Korea and Thailand accelerating deal talks.

THD
iShares MSCI Thailand ETF

Feed

News

Sentiment

Fundamentals

Info

Latest THD News

THDiShares MSCI Thailand ETF